Biopolym. Cell. 2017; 33(1):34-47.
http://dx.doi.org/10.7124/bc.000940
Molecular Biomedicine
Analysis of mutations in GBA gene in Ukrainian patients with Gaucher disease
1Olkhovych N. V., 1Nedoboy A. M., 1Pichkur N. O., 1Gorovenko N. H.
  1. State Institute of Genetic and Regenerative Medicine, NAMS of Ukraine
    67, Vyshhorodska Str., Kyiv, Ukraine, 04114
  2. National Children's Specialized Hospital Okhmatdyt, Ministry of Health of Ukraine
    28/1, Chornovola Str., Kyiv, Ukraine, 01135

Abstract

Gaucher disease (MIM 230800) is the most common storage disorder, caused by hereditary deficiency of the lysosomal enzyme of glucocerebrosidase (EC 3.2.1.45). Human glucocerebrosidase gene (GBA) is mapped to the 1q21 locus, it is 7.5 kb long and consists of 11 exons. According to human gene mutation databases, there are over 300 currently described pathogenic GBA variants, most of them are related to the development of Gaucher disease. Aim. To identify rearrangements in the GBA gene which conditioned the development of Gaucher disease in Ukrainian patients, to compare their spectrum with the variants in patients from Slavonic and other European countries and to evaluate genotype-phenotype associations for this disease. Methods. The Sanger’s method of direct automated sequencing using ABI 3130 analyzer (Applied Biosystems). Results. We identified 96.8 % of mutant alleles in Ukrainian patients with Gaucher disease. Six new and previously not described rearrangements of the GBA gene were identified. Conclusion. The comparison of genotypes with the linical form of the disease demonstrated that our results agree with the currently recognized genotype-phenotype correlations, which allow predicting the type and clinical course of the Gaucher disease to some degree.
Keywords: Gaucher disease, GBA gene
Full text: (PDF, in English)

References

[1] Lysosomal storage disorders: a practical guide. Eds: Mehta A, Winchester B. London: Wiley-Blackwell, 2012; 208 p.
[2] Beutler E, Grabowski GA. Gaucher disease. In: The metabolic & molecular bases of inherited diseases. Eds. Scriver CR, Beaudet AL, Sly WS, Valle D. New York: McGraw-Hill, 2009; 3668 p.
[3] Horowitz M, Wilder S, Horowitz Z, Reiner O, Gelbart T, Beutler E. The human glucocerebrosidase gene and pseudogene: structure and evolution. Genomics. 1989;4(1):87-96.
[4] Winfield SL, Tayebi N, Martin BM, Ginns EI, Sidransky E. Identification of three additional genes contiguous to the glucocerebrosidase locus on chromosome 1q21: implications for Gaucher disease. Genome Res. 1997;7(10):1020-6.
[5] Hruska KS, LaMarca ME, Scott CR, Sidransky E. Gaucher disease: mutation and polymorphism spectrum in the glucocerebrosidase gene (GBA). Hum Mutat. 2008;29(5):567-83.
[6] Beutler E, Gelbart T. Erroneous assignment of Gaucher disease genotype as a consequence of a complete gene deletion. Hum Mutat. 1994;4(3):212-6.
[7] Koprivica V, Stone DL, Park JK, Callahan M, Frisch A, Cohen IJ, Tayebi N, Sidransky E. Analysis and classification of 304 mutant alleles in patients with type 1 and type 3 Gaucher disease. Am J Hum Genet. 2000;66(6):1777-86.
[8] Hatton CE, Cooper A, Whitehouse C, Wraith JE. Mutation analysis in 46 British and Irish patients with Gaucher's disease. Arch Dis Child. 1997;77(1):17-22.
[9] Germain DP, Puech JP, Caillaud C, Kahn A, Poenaru L. Exhaustive screening of the acid beta-glucosidase gene, by fluorescence-assisted mismatch analysis using universal primers: mutation profile and genotype/phenotype correlations in Gaucher disease. Am J Hum Genet. 1998;63(2):415-27.
[10] Erdos M, Hodanova K, Taskó S, Palicz A, Stolnaja L, Dvorakova L, Hrebicek M, Maródi L. Genetic and clinical features of patients with Gaucher disease in Hungary. Blood Cells Mol Dis. 2007;39(1):119-23.
[11] Malini E, Grossi S, Deganuto M, Rosano C, Parini R, Dominisini S, Cariati R, Zampieri S, Bembi B, Filocamo M, Dardis A. Functional analysis of 11 novel GBA alleles. Eur J Hum Genet. 2014;22(4):511-6.
[12] Alfonso P, Aznarez S, Giralt M, Pocovi M, Giraldo P; Spanish Gaucher's Disease Registry.. Mutation analysis and genotype/phenotype relationships of Gaucher disease patients in Spain. J Hum Genet. 2007;52(5):391-6.
[13] Hodanová K, Hrebícek M, Cervenková M, Mrázová L, Vepreková L, Zemen J. Analysis of the beta-glucocerebrosidase gene in Czech and Slovak Gaucher patients: mutation profile and description of six novel mutant alleles. Blood Cells Mol Dis. 1999;25(5-6):287-98.
[14] Mattošová S, Chandoga J, Hlavatá A, Saligová J, Maceková D. Spectrum of GBA mutations in patients with Gaucher disease from Slovakia: identification of five novel mutations. Isr Med Assoc J. 2015;17(3):166-70.
[15] Tylki-Szymañska A, Keddache M, Grabowski GA. Characterization of neuronopathic Gaucher disease among ethnic Poles. Genet Med. 2006;8(1):8-15.
[16] Boukina TM, Tsvetkova IV. Distribution of mutations of acid b-d-glucosidase gene (GBA) among 68 russian patients with Gaucher’s disease. Biochemistry (Moscow) Suppl Ser B: Biomed Chem. 2008; 2(1):105–10.
[17] Horovenko NH, Ol'khovych NV, NedoboÄ­ AM, Pichkur NO. [Detection of the frequencies of GBA gene major mutations in patients with Gaucher disease in Ukraine]. Tsitol Genet. 2007;41(4):41-7.
[18] Miocić S, Filocamo M, Dominissini S, Montalvo AL, Vlahovicek K, Deganuto M, Mazzotti R, Cariati R, Bembi B, Pittis MG. Identification and functional characterization of five novel mutant alleles in 58 Italian patients with Gaucher disease type 1. Hum Mutat. 2005;25(1):100.
[19] den Dunnen JT, Dalgleish R, Maglott DR, Hart RK, Greenblatt MS, McGowan-Jordan J, Roux AF, Smith T, Antonarakis SE, Taschner PE. HGVS Recommendations for the Description of Sequence Variants: 2016 Update. Hum Mutat. 2016;37(6):564-9.
[20] Zimran A, Kay A, Gelbart T, Garver P, Thurston D, Saven A, Beutler E. Gaucher disease. Clinical, laboratory, radiologic, and genetic features of 53 patients. Medicine (Baltimore). 1992;71(6):337-53.
[21] Amaral O, Marcão A, Sá Miranda M, Desnick RJ, Grace ME. Gaucher disease: expression and characterization of mild and severe acid beta-glucosidase mutations in Portuguese type 1 patients. Eur J Hum Genet. 2000;8(2):95-102.
[22] Cormand B, Grinberg D, Gort L, Fiumara A, Barone R, Vilageliu L, Chabás A. Two new mild homozygous mutations in Gaucher disease patients: clinical signs and biochemical analyses. Am J Med Genet. 1997;70(4):437-43.
[23] Stone DL, Tayebi N, Orvisky E, Stubblefield B, Madike V, Sidransky E. Glucocerebrosidase gene mutations in patients with type 2 Gaucher disease. Hum Mutat. 2000;15(2):181-8.
[24] Dvir H, Harel M, McCarthy AA, Toker L, Silman I, Futerman AH, Sussman JL. X-ray structure of human acid-beta-glucosidase, the defective enzyme in Gaucher disease. EMBO Rep. 2003;4(7):704-9.
[25] Atrian S, López-Viñas E, Gómez-Puertas P, Chabás A, Vilageliu L, Grinberg D. An evolutionary and structure-based docking model for glucocerebrosidase-saposin C and glucocerebrosidase-substrate interactions - relevance for Gaucher disease. Proteins. 2008;70(3):882-91.
[26] Cormand B, Grinberg D, Gort L, Chabás A, Vilageliu L. Molecular analysis and clinical findings in the Spanish Gaucher disease population: putative haplotype of the N370S ancestral chromosome. Hum Mutat. 1998;11(4):295-305.